Dr. Reddy’s Laboratories RDY and China-based Bio-Thera Solutions announced that they have entered into commercialization and license agreements for BAT2206, a proposed biosimilar of Johnson & ...

The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

Medically reviewed by Anita C. Chandrasekaran, MD Many people associate psoriatic arthritis (PsA) with itchy, scaly skin and ...

Affiliate content. Discover the best products for arthritis in hands, including supplements, creams, and tools designed to ...

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...

Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

Posters presented at the 2025 American Academy of Dermatology Annual Meeting found bimekizumab to have benefits beyond safety ...

IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.

Researchers are investigating a variety of treatment options, such as: Some evidence suggests that COVID can cause reactive arthritis in the post-infectious stage by attacking the musculoskeletal ...

Explore top treatments to tackle stubborn fungal nail infections, with expert guidance from podiatrist Tamara Guerreiro Iglesias. The Standard's journalism is supported by our readers. When you ...

Switching to an anti-inflammatory diet could significantly reduce arthritis symptoms in just eight weeks, according to Dr. Tamiko Katsumoto. Focusing on whole food, plant-based diets and ...